MAINZ BIOMED N.V.
Amendment
CIK: 0001874252·Biotechnology·NETHERLANDS·Filed: May 10, 2024
Total Offering
$50,000,000
Amount Sold
$14,300,000
Investors
1
First Sale
Jun 28, 2023
Offering Details
- Type
- Equity, Debt, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2021
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| William Caragol | Related Person |
| Guido Baechler | Related Person |
| Moritz Eidens | Related Person |
| Heiner Dreismann | Related Person |
| Nicole Holden | Related Person |
| Hans Hekland | Related Person |
| Alberto Libanori | Related Person |
| Phillip Freese | Related Person |
| Darin Leigh | Related Person |
| Gregory Tibbits | Related Person |
Company
SEC Filing
0001213900-24-041832
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free